Brolucizumab - Novartis
At a glance
- Drug Originator ESBATech
- Drug Class Antibodies; Eye disorder therapies; Immunoglobulin Fv fragments; Monoclonal antibodies
- Mechanism of Action Angiogenesis inhibitors; Vascular endothelial growth factor A inhibitors
- USA Patent Applicants NOVARTIS PHARMS CORP
- USA Patents 1
- BLAs 1
Table of Contents

Disclaimer